Neurofilament phosphoforms: Surrogate markers for axonal injury, degeneration and loss

Axonal transection in the lesions of multiple sclerosis

Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029

The cell: a molecular approach

(1997) · Choice Reviews Online · doi:10.5860/choice.35-0264 · Cited by 1,465

Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ.

Sternberger, L. A., & Sternberger, N. H. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.19.6126 · Cited by 1,158

A Structural Scaffolding of Intermediate Filaments in Health and Disease

Fuchs, E. V., & Cleveland, D. W. (1998) · Science · doi:10.1126/science.279.5350.514 · Cited by 1,013

The slow component of axonal transport. Identification of major structural polypeptides of the axon and their generality among mammalian neurons.

Hoffman, P. N., & Lasek, R. J. (1975) · The Journal of Cell Biology · doi:10.1083/jcb.66.2.351 · Cited by 941

Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells

de Waegh, S. M., Lee, V. M. ‐., & Brady, S. T. (1992) · Cell · doi:10.1016/0092-8674(92)90183-d · Cited by 743

Neurofilament gene expression: a major determinant of axonal caliber.

Hoffman, P. N., Cleveland, D. W., Griffin, J. W., Landes, P. W., Cowan, N. J., & Price, D. L. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.10.3472 · Cited by 719

A Mechanistic Analysis of Nondisruptive Axonal Injury: A Review

Maxwell, W. L., Povlishock, J. T., & Graham, D. I. (1997) · Journal of Neurotrauma · doi:10.1089/neu.1997.14.419 · Cited by 564

Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease

Xu, Z. (1993) · Cell · doi:10.1016/0092-8674(93)90157-l · Cited by 543

Minocycline Provides Neuroprotection Against N -Methyl- d -aspartate Neurotoxicity by Inhibiting Microglia

Tikka, T., & Koıstınaho, J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7527 · Cited by 539

Molecular mechanisms of neurofilament alterations and its application in assessing neurodegenerative disorders

Devarakonda, S., Basha, S., Pithakumar, A., Thoshna, L. B., Mukunda, D. C., Rodrigues, J., Ameera, K., Biswas, S., Pai, A. R., Belurkar, S., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102566 · Cited by 30

Accelerated Brain Aging in Mild Traumatic Brain Injury: Longitudinal Pattern Recognition with White Matter Integrity

Gan, S., Shi, W., Wang, S., Sun, Y., Yin, B., Bai, G., Jia, X., Sun, C., Niu, X., Wang, Z., et al. (2021) · Journal of Neurotrauma · doi:10.1089/neu.2020.7551 · Cited by 31

Potential Biomarkers Associated with Multiple Sclerosis Pathology

Mathur, D., Mishra, B. K., Rout, S., Lopez-Iranzo, F. J., López‐Rodas, G., Vallamkondu, J., Kandimalla, R. J. L., & Casanova, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910323 · Cited by 32

Cathepsin D as biomarker in cerebrospinal fluid of nusinersen‐treated patients with spinal muscular atrophy

Schorling, D., Kölbel, H., Hentschel, A., Pechmann, A., Meyer, N., Wirth, B., Rombo, R., Sickmann, A., Kirschner, J., Schara, U., et al. (2022) · European Journal of Neurology · doi:10.1111/ene.15331 · Cited by 27

Cerebrospinal fluid proteomics and protein biomarkers in frontotemporal lobar degeneration: Current status and future perspectives

Oeckl, P., Steinacker, P., Feneberg, E., & Otto, M. (2014) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2014.12.010 · Cited by 28

Congenital hypothyroidism is associated with intermediate filament misregulation, glutamate transporters down-regulation and MAPK activation in developing rat brain

Zamoner, A., Heimfarth, L., & Pessoa‐Pureur, R. (2008) · NeuroToxicology · doi:10.1016/j.neuro.2008.09.004 · Cited by 27

Diagnostic performance of new and classic CSF biomarkers in age-related dementias

Marchegiani, F., Matacchione, G., Ramini, D., Marcheselli, F., Recchioni, R., Casoli, T., Mercuri, E., Lazzarini, M., Giorgetti, B., Cameriere, V., et al. (2019) · Aging · doi:10.18632/aging.101925 · Cited by 27

Plasma Neurofilament Light and Alzheimer’s Disease Biomarkers in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI)

Rafii, M. S., Donohue, M., Matthews, D. C., Muranevici, G., Ness, S. L., O’Bryant, S. E., & Rissman, R. A. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190322 · Cited by 26

Therapeutic Response and Possible Biomarkers in Acute Attacks of Neuromyelitis Optica Spectrum Disorders: A Prospective Observational Study

Wang, J., Cui, C., Lu, Y., Chang, Y., Wang, Y., Li, R., Shan, Y., Sun, X., Long, Y., Wang, H., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.720907 · Cited by 26

MRI and fluid biomarkers reveal determinants of myelin and axonal loss with aging

Walker, K. A., Duggan, M. R., Gong, Z., Dark, H. E., Laporte, J. P., Faulkner, M. E., An, Y., Lewis, A., Moghekar, A., Resnick, S. M., et al. (2023) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51730 · Cited by 25

Noninvasive detection of brainstem and spinal cord axonal degeneration in an amyotrophic lateral sclerosis mouse model

Kim, J. H., Wu, T., Budde, M. D., Lee, J., & Song, S. (2010) · NMR in Biomedicine · doi:10.1002/nbm.1567 · Cited by 26

Plasma concentration of neurofilament light chain protein decreases after switching from tenofovir disoproxil fumarate to tenofovir alafenamide fumarate

Hermansson, L., Yilmaz, A., Price, R. W., Nilsson, S., McCallister, S. H., Makadzange, T., Das, M., Zetterberg, H., Blennow, K., & Gisslén, M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0226276 · Cited by 26

Progressive Supranuclear Palsy Syndrome: An Overview

Ichikawa-Escamilla, E., Velasco-Martínez, R. A., & Adalid-Peralta, L. V. (2024) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2024.04.008 · Cited by 31

Serial cerebrospinal fluid neurofilament concentrations in bacterial meningitis

Matsushige, T., Ichiyama, T., Kajimoto, M., Okuda, M., Fukunaga, S., & Furukawa, S. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.01.021 · Cited by 25

Plasticity of synaptic endings in the cochlear nucleus following noise‐induced hearing loss is facilitated in the adult FGF2 overexpressor mouse

D'Sa, C., Gross, J., Francone, V. P., & Morest, D. K. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05695.x · Cited by 25

Serum and cerebrospinal fluid heavy neurofilaments and antibodies against them in early multiple sclerosis

Fialová, L., Bartoš, A., Švarcová, J., Zimová, D., & Kotoucova, J. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.03.009 · Cited by 25

Spirulina platensis protects neurons via suppression of glial activation and peripheral sensitization leading to restoration of motor function in collagen-induced arthritic rats.

Patro, N., Sharma, A., Kariaya, K., & Patro, I. K. (2011) · PubMed · Cited by 25

The neurofilament light chain is not stable in vitro

Koel‐Simmelink, M. J. A., Teunissen, C. E., Behradkia, P., Blankenstein, M. A., & Petzold, A. (2011) · Annals of Neurology · doi:10.1002/ana.22438 · Cited by 25

Performance of Plasma Amyloid β, Total Tau, and Neurofilament Light Chain in the Identification of Probable Alzheimer's Disease in South China

Jiao, B., Liu, H., Guo, L., Liao, X., Zhou, Y., Weng, L., Xiao, X., Zhou, L., Wang, X., Jiang, Y., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.749649 · Cited by 34

Changes in self-reactive IgG antibody repertoire after treatment of experimental autoimmune encephalomyelitis with anti-allergic drugs

Behi, M. E., Zéphir, H., Lefranc, D., Dutoit, V., Dussart, P., Devos, P., Dessaint, J., Vermersch, P., & Prin, L. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.10.002 · Cited by 24

The Complement Regulator Susd4 Influences Nervous-System Function and Neuronal Morphology in Mice

Zhu, H., Meissner, L. E., Byrnes, C., Tuymetova, G., Tifft, C. J., & Proia, R. L. (2020) · iScience · doi:10.1016/j.isci.2020.100957 · Cited by 24

Longitudinal one-year study of levels and stoichiometry of neurofilament heavy and light chain concentrations in CSF in patients with multiple system atrophy

Petzold, A., Thompson, E. J., Keir, G., Quinn, N. P., Holmberg, B., Dizdar, N., Wenning, G. K., Rascol, O., TOLOSA, E. S., & Rosengren, L. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.12.037 · Cited by 24

Present and Future of Blood-Based Biomarkers of Alzheimer’s Disease: Beyond the Classics

Grigoli, M. M., Pelegrini, L. N. D. C., Whelan, R., & Cominetti, M. R. (2024) · Brain Research · doi:10.1016/j.brainres.2024.148812 · Cited by 22

Blood molecular biomarkers for chemotherapy-induced peripheral neuropathy: From preclinical models to clinical practice

Meregalli, C., Bonomo, R., Cavaletti, G., & Carozzi, V. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.135739 · Cited by 23

Recent Advances in Frontotemporal Dementia

Tartaglia, M. C., & Mackenzie, I. R. (2022) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2022.69 · Cited by 26

Serum neurofilament light chain levels are associated with all-cause mortality in the general US population

Ciardullo, S., Muraca, E., Bianconi, E., Ronchetti, C., Cannistraci, R., Rossi, L., Perra, S., Zerbini, F., & Perseghin, G. (2023) · Journal of Neurology · doi:10.1007/s00415-023-11739-6 · Cited by 23

Neurochemical Evidence of Potential Neurotoxicity After Prophylactic Cranial Irradiation

Kalm, M., Abel, E., Wasling, P., Nyman, J., Hietala, M. A., Bremell, D., Hagberg, L., Elam, M., Blennow, K., Björk‐Eriksson, T., et al. (2014) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2014.03.019 · Cited by 22

Cytoskeleton as a potential target in the neuropathology of maple syrup urine disease: Insight from animal studies

Pessoa‐Pureur, R., & Wajner, M. (2007) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-007-0562-6 · Cited by 23

Neurofilament stoichiometry simulations during neurodegeneration suggest a remarkable self-sufficient and stable in vivo protein structure

Kim, S., Chang, R., Teunissen, C. E., Gebremichael, Y., & Petzold, A. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.04.023 · Cited by 23

Dextran-based biodegradable nanoparticles: an alternative and convenient strategy for treatment of traumatic spinal cord injury

Liu, W., Quan, P., Li, Q., Tang, P., Chen, J., Jiang, T., & Cai, W. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s171925 · Cited by 23

ALS Yeast Models—Past Success Stories and New Opportunities

Gregorio, S. E. D., & Duennwald, M. L. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00394 · Cited by 27

Neurofilament protein levels: Quantitative analysis in essential tremor cerebellar cortex

Louis, E. D., Ma, K., Babij, R., Cortes, E. P., Liem, R. K. H., Vonsattel, J., & Faust, P. L. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.04.054 · Cited by 23

Detection of Cerebrospinal Fluid Neurofilament Light Chain as a Marker for Alpha-Synucleinopathies

Canaslan, S., Schmitz, M., Villar‐Piqué, A., Maass, F., Gmitterová, K., Varges, D., Lingor, P., Llorens, F., Hermann, P., & Zerr, I. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.717930 · Cited by 22

Neurofilament Levels Are Reflecting the Loss of Presynaptic Dopamine Receptors in Movement Disorders

Diekämper, E., Brix, B., STÖCKER, W., Vielhaber, S., Galazky, I., Kreissl, M. C., Genseke, P., Düzel, E., & Körtvelyessy, P. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.690013 · Cited by 23

Shared CSF Biomarker Profile in Idiopathic Normal Pressure Hydrocephalus and Subcortical Small Vessel Disease

Jeppsson, A., Bjerke, M., Hellström, P., Blennow, K., Zetterberg, H., Kettunen, P., Wikkelsø, C., Wallin, A., & Tullberg, M. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.839307 · Cited by 22

Longitudinal analyses of serum neurofilament light and associations with obesity indices and bioelectrical impedance parameters

Hermesdorf, M., Leppert, D., Maceski, A. M., Benkert, P., Wellmann, J., Wiendl, H., Kühle, J., & Berger, K. (2022) · Scientific Reports · doi:10.1038/s41598-022-20398-y · Cited by 22

An augmentation in histone dimethylation at lysine nine residues elicits vision impairment following traumatic brain injury

Gupta, R. K., Saha, P., Sen, T., & Sen, N. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.02.015 · Cited by 22

Neurofilament light chain as a biomarker of meningoencephalitis of unknown etiology in dogs

Yun, T., Koo, Y., Chae, Y., Lee, D., Kim, H., Kim, S., Chang, D., Na, K., Yang, M., & Kang, B. (2021) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.16184 · Cited by 21

Differential aspects of immune cell infiltration and neurodegeneration in acute and relapse experimental autoimmune encephalomyelitis

Soellner, I. A., Rabe, J. L., Mauri, V., Kaufmann, J., Addicks, K., & Küerten, S. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.10.011 · Cited by 21

Science is 1% inspiration and 99% biomarkers

Dubuisson, N., Puentes, F., Giovannoni, G., & Gnanapavan, S. (2017) · Multiple Sclerosis Journal · doi:10.1177/1352458517709362 · Cited by 22

Blood-based Biomarkers of Alzheimer’s Disease: The Long and Winding Road

Manzine, P. R., Vatanabe, I. P., Peron, R., Grigoli, M. M., Pedroso, R. V., Nascimento, C. M. C., & Cominetti, M. R. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200114105515 · Cited by 22

Neurofilaments as Emerging Biomarkers of Neuroaxonal Damage to Differentiate Behavioral Frontotemporal Dementia from Primary Psychiatric Disorders: A Systematic Review

Davy, V., Dumurgier, J., Fayossé, A., Paquet, C., & Cognat, E. (2021) · Diagnostics · doi:10.3390/diagnostics11050754 · Cited by 20

Honey Bee Larval Hemolymph as a Source of Key Nutrients and Proteins Offers a Promising Medium for Varroa destructor Artificial Rearing

Piou, V., Vilarem, C., Blanchard, S., Strub, J., Bertile, F., Bocquet, M., Arafah, K., Bulet, P., & Vétillard, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512443 · Cited by 20

Phosphorylated Neurofilament Heavy Chain Correlations to Visual Function, Optical Coherence Tomography, and Treatment

Pasol, J., Feuer, W. J., Yang, C., Shaw, G., Kardon, R. H., & Guy, J. R. (2010) · Multiple Sclerosis International · doi:10.1155/2010/542691 · Cited by 20

Cerebrospinal fluid light and heavy neurofilaments in neuromyelitis optica

Wang, H., Wang, C., Qiu, W., Lu, Z., Hu, X., & Wang, K. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.10.008 · Cited by 20

The Diagnostic and Prognostic Value of Neurofilament Heavy Chain Levels in Immune-Mediated Optic Neuropathies

Petzold, A., & Plant, G. T. (2012) · Multiple Sclerosis International · doi:10.1155/2012/217802 · Cited by 21

Correlations between macrophage/microglial activation marker sTREM-2 and measures of T-cell activation, neuroaxonal damage and disease severity in multiple sclerosis

Ioannides, Z. A., Csurhes, P. A., Swayne, A., Foubert, P., Aftab, B. T., & Pender, M. P. (2021) · Multiple Sclerosis Journal - Experimental Translational and Clinical · doi:10.1177/20552173211019772 · Cited by 21

Accumulation of amyloid-β in the cerebellar cortex of essential tremor patients

Béliveau, É., Tremblay, C., Aubry-Lafontaine, É., Paris‐Robidas, S., Delay, C., Robinson, C. A., Ferguson, L., Rajput, A. H., Rajput, A. H., & Calon, F. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.07.016 · Cited by 22

Plasma neurofilament heavy chain levels in Huntington's disease

Wild, E. J., Petzold, A., Keir, G., & Tabrizi, S. J. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.02.053 · Cited by 20

Proteomics of cerebral injury in a neonatal model of cardiopulmonary bypass with deep hypothermic circulatory arrest

Sheikh, A. M., Barrett, C., Villamizar, N. R., Álzate, Ó., Miller, S., Shelburne, J. D., Lodge, A. W., Lawson, J., & Jaggers, J. J. (2006) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2006.07.002 · Cited by 20

Cerebrospinal fluid and blood neurofilament light chain in Parkinson's disease and atypical parkinsonian syndromes: a systematic review and Bayesian network meta-analysis

Kou, W., Li, S., Yan, R., Zhang, J., Wan, Z., & Feng, T. (2025) · Journal of Neurology · doi:10.1007/s00415-025-13051-x · Cited by 22

Plasma Neurofilament Light (NfL) in Patients Affected by Niemann–Pick Type C Disease (NPCD)

Dardis, A., Pavan, E., Fabris, M., Riol, R. M. D., Sechi, A., Fiumara, A., Santoro, L., Ormazábal, M., Milanič, R., Zampieri, S., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10204796 · Cited by 18

Neurofilament Light Chain (NF‐L) Stimulates Lipid Peroxidation to Neuronal Membrane through Microglia‐Derived Ferritin Heavy Chain (FTH) Secretion

Gong, L., Yu, Q., Wang, H., Xu, C., Dou, Y., Mao, B., & Zhao, Y. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/3938940 · Cited by 19

Plasma neurofilament light chain: A biomarker predicting severity in patients with acute ischemic stroke

Wu, J., Wu, D., Liang, Y., Zhang, Z., Zhuang, L., & Wang, Z. (2022) · Medicine · doi:10.1097/md.0000000000029692 · Cited by 19

The role of neurofilament light in genetic frontotemporal lobar degeneration

Zetterberg, H., Teunissen, C., van Swieten, J., Kuhle, J., Boxer, A., Rohrer, J. D., Mitic, L., Nicholson, A. M., Pearlman, R., McCaughey, S. M., et al. (2022) · Brain Communications · doi:10.1093/braincomms/fcac310 · Cited by 19

An Increase in Tolerogenic Dendritic Cell and Natural Regulatory T Cell Numbers during Experimental Autoimmune Encephalomyelitis in Rras−/− Mice Results in Attenuated Disease

Ray, A., Basu, S., Miller, N. M., Chan, A. M.-L., & Dittel, B. N. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302254 · Cited by 19

Noninvasive Assessments of Optic Nerve Neurodegeneration in Transgenic Mice With Isolated Optic Neuritis

Talla, V., Yang, C., Shaw, G., Porciatti, V., Koilkonda, R. D., & Guy, J. R. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-11899 · Cited by 19

The Use of Blood-Based Biomarkers to Improve the Design of Clinical Trials of Traumatic Brain Injury

Glushakova, O. Y., Glushakov, A. V., Mannix, R., Miller, E. R., Valadka, A. B., & Hayes, R. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804064-5.00008-4 · Cited by 19

Neurotoxic Effect of Fipronil in Neuroblastoma SH-SY5Y Cell Line

Toprak, Ö., & Selmanoğlu, G. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-00093-z · Cited by 19

Neurofilament‐light in former athletes: a potential biomarker of neurodegeneration and progression

Taghdiri, F., Multani, N., Ozzoude, M., Tarazi, A., Khodadadi, M., Wennberg, R. A., Mikulis, D. J., Green, R., Colella, B., Davis, K. D., et al. (2020) · European Journal of Neurology · doi:10.1111/ene.14251 · Cited by 19

Quantitative susceptibility mapping and blood neurofilament light chain differentiate between parkinsonian disorders

Zhang, P., Chen, J., Cai, T., He, C., Li, Y., Li, X., Chen, Z., Wang, L., & Zhang, Y. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.909552 · Cited by 19

Phosphorylation of neurofilament subunit NF‐M is regulated by activation of NMDA receptors and modulates cytoskeleton stability and neuronal shape

Fiumelli, H., Riederer, I. M., Martin, J., & Riederer, B. M. (2008) · Cell Motility and the Cytoskeleton · doi:10.1002/cm.20278 · Cited by 19

Cerebrospinal fluid neurofilament: the biomarker that will resuscitate the ‘Spinal Tap’

Giovannoni, G. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458510361358 · Cited by 19

Cerebellar Calcium-Binding Protein and Neurotrophin Receptor Defects in Down Syndrome and Alzheimer's Disease

Miguel, J. C., Perez, S. E., Malek‐Ahmadi, M. H., & Mufson, E. J. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.645334 · Cited by 17

Electrochemical Quantitation of the Glycosylation Level of Serum Neurofilament Light Chain for the Diagnosis of Neurodegeneration: An Interface-Solution Dual-Path Amplification Strategy

Zhou, S., Liu, D., Chen, J., Xiang, C. J., Xiang, J., & Yang, M. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c02753 · Cited by 19

Serum neurofilament light chain and cognition decline in US elderly: A cross‐sectional study

Liu, X., Chen, J., Meng, C., Zhou, L., & Liu, Y. (2023) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51929 · Cited by 17

Preventive and therapeutic effects of the selective Rho-kinase inhibitor fasudil on experimental autoimmune neuritis

Pineda, A. A. M., Minohara, M., Kawamura, N., Matsushita, T., Yamasaki, R., Sun, X., Piao, H. Z., Shimokawa, H., & Kira, J. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.03.031 · Cited by 18

The Validation Study of Neurofilament Heavy Chain and 8-hydroxy-2′-deoxyguanosine as Plasma Biomarkers of Clinical/Paraclinical Activity in First and Relapsing-Remitting Demyelination Acute Attacks

Ljubisavljević, S., Stojanović, I. R., Bašić, J., & Pavlović, D. (2016) · Neurotoxicity Research · doi:10.1007/s12640-016-9639-z · Cited by 18

Treatment resistance in major depression is correlated with increased plasma levels of neurofilament light protein reflecting axonal damage

Spanier, S., Kilian, H. M., Meyer, D. M., & Schlaepfer, T. E. (2019) · Medical Hypotheses · doi:10.1016/j.mehy.2019.03.022 · Cited by 19

Protein aggregate formation permits millennium-old brain preservation

Petzold, A., Lu, C., Groves, M., Gobom, J., Zetterberg, H., Shaw, G., & O’Connor, S. (2020) · Journal of The Royal Society Interface · doi:10.1098/rsif.2019.0775 · Cited by 17

Elevated Levels of Carbonyl Proteins in Cerebrospinal Fluid of Patients with Neurodegenerative Diseases

Rommer, P. S., Greilberger, J., Salhofer‐Polanyi, S., Auff, E., Leutmezer, F., & Herwig, R. (2014) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.234.313 · Cited by 18

Effects of in vivo treatment with diphenyl ditelluride on the phosphorylation of cytoskeletal proteins in cerebral cortex and hippocampus of rats

Heimfarth, L., Loureiro, S. O., Zamoner, A., Pelaez, P. D. L., Nogueira, C. W., da Rocha, J. B. T., & Pessoa‐Pureur, R. (2007) · NeuroToxicology · doi:10.1016/j.neuro.2007.08.012 · Cited by 18

Plasma neurofilament heavy chain is not a useful biomarker in Charcot-Marie-Tooth disease

Rossor, A. M., Liu, C.-H., Petzold, A., Malaspina, A., Laurá, M., Greensmith, L., & Reilly, M. M. (2016) · Muscle & Nerve · doi:10.1002/mus.25124 · Cited by 18

Serum neurofilament light chain or glial fibrillary acidic protein in the diagnosis and prognosis of brain metastases

Lin, X., Lü, T., Deng, H., Liu, C., Yang, Y., Chen, T., Qin, Y., Xie, X., Xie, Z., Liu, M., et al. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10660-0 · Cited by 17

Exploring Neurofilament Light Chain and Exosomes in the Genetic Forms of Frontotemporal Dementia

Zanardini, R., Saraceno, C., Benussi, L., Squitti, R., & Ghidoni, R. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.758182 · Cited by 17

Is essential tremor a degenerative disorder or an electric disorder? Degenerative disorder

Faust, P. L. (2022) · International review of neurobiology · doi:10.1016/bs.irn.2022.02.003 · Cited by 17

Neurofilaments in neurologic disorders and beyond

Mak, G. K., Menon, S., & Lu, J. (2022) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2022.120380 · Cited by 18

An overview of peripapillary hyperreflective ovoid mass-like structures

Jeon-Chapman, J. G., Heidary, G., & Gise, R. A. (2022) · Current Opinion in Ophthalmology · doi:10.1097/icu.0000000000000897 · Cited by 17

Blood-Based Biomarkers in the Diagnosis of Chronic Traumatic Encephalopathy: Research to Date and Future Directions

Halicki, M. J., Hind, K., & Chazot, P. L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612556 · Cited by 20

The heritability of blood‐based biomarkers related to risk of Alzheimer's disease in a population‐based sample of early old‐age men

Gillespie, N. A., Elman, J. A., McKenzie, R. E., Tu, X. M., Xian, H., Reynolds, C. A., Panizzon, M. S., Lyons, M. J., Eglit, G. M. L., Neale, M. C., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13407 · Cited by 13

Association between urinary glyphosate levels and serum neurofilament light chain in a representative sample of US adults: NHANES 2013–2014

Yang, A., Chu, P., Wang, C., & Lin, C. (2023) · Journal of Exposure Science & Environmental Epidemiology · doi:10.1038/s41370-023-00594-2 · Cited by 20

Docking protein 6 (DOK6) selectively docks the neurotrophic signaling transduction to restrain peripheral neuropathy

Guo, Y., Xiang, P., Sun, X., Liu, W., Zhou, J., Yin, B., Hou, L., Qiang, B., Li, H., Shu, P., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01742-2 · Cited by 17

Blood and CSF Biomarker Dynamics in Multiple Sclerosis: Implications for Data Interpretation

Eikelenboom, M. J., Uitdehaag, B. M. J., & Petzold, A. (2011) · Multiple Sclerosis International · doi:10.1155/2011/823176 · Cited by 18

Topographic regulation of neuronal intermediate filaments by phosphorylation, role of peptidyl-prolyl isomerase 1: significance in neurodegeneration

Binukumar, B. K., Shukla, V., Amin, N. D., Reddy, P., Skuntz, S., Grant, P. G., & Pant, H. C. (2013) · Histochemistry and Cell Biology · doi:10.1007/s00418-013-1108-7 · Cited by 17

Disease activity in progressive multiple sclerosis can be effectively reduced by cladribine

Yildiz, Ö., Mao, Z., Adams, A., Dubuisson, N., Allen‐Philbey, K., Giovannoni, G., Malaspina, A., Baker, D., Gnanapavan, S., & Schmierer, K. (2018) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2018.05.010 · Cited by 17

Axonopathy and Reduction of Membrane Resistance: Key Features in a New Murine Model of Human GM1-Gangliosidosis

Eikelberg, D. J., Lehmbecker, A., Brogden, G., Tongtako, W., Hahn, K., Habierski, A., Hennermann, J. B., Naim, H. Y., Felmy, F., Baumgärtner, W., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9041004 · Cited by 17

Neurofilament light chain is a cerebrospinal fluid biomarker in hereditary spastic paraplegia

Kessler, C., Serna-­Higuita, L. M., Rattay, T. W., Maetzler, W., Wurster, I., Hayer, S. N., Wilke, C., Hengel, H., Reichbauer, J., Armbruster, M., et al. (2021) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51358 · Cited by 17

Synergy of Serum and Cerebrospinal Fluid Antibodies Against Axonal Cytoskeletal Proteins in Patients with Different Neurological Diseases

Fialová, L., Bartoš, A., Soukupová, J., Švarcová, J., Ridzoň, P., & Malbohan, I. M. (2009) · Folia Biologica · doi:10.14712/fb2009055010023 · Cited by 17

Serum neurofilament light chain, brain infarcts, and the risk of stroke: a prospective population-based cohort study

Dhana, A., DeCarli, C. S., Aggarwal, N. T., Dhana, K., Desai, P., Evans, D. A., & Rajan, K. B. (2023) · European Journal of Epidemiology · doi:10.1007/s10654-023-00978-6 · Cited by 16

Multicenter Immunoassay Validation of Cerebrospinal Fluid Neurofilament Light: A Biomarker for Neurodegeneration

Miller, A.-M., Rutkowska, A., Bahl, J. M. C., Herukka, S., Simmelink, M. J. A., Kruse, N., Mollenhauer, B., Siloaho, M., Skinningsrud, A., Zetterberg, H., et al. (2016) · Bioanalysis · doi:10.4155/bio-2016-0114 · Cited by 16

Differential Impact of Neurofilament Light Subunit on Cognition and Functional Outcome in Memory Clinic Patients with and without Vascular Burden

Rolstad, S., Berg, A. I., Eckerström, C., Johansson, B. E. A., & Wallin, A. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142694 · Cited by 15

Early manifestations of epileptic encephalopathy, brain atrophy, and elevation of serum neuron specific enolase in a boy with beta-propeller protein-associated neurodegeneration

Takano, K., Goto, K., Motobayashi, M., Wakui, K., Kawamura, R., Yamaguchi, T., Fukushima, Y., & Kosho, T. (2017) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2017.07.008 · Cited by 16

Biomarkers of Brain Injury and Neurological Disorders

(2014) · CRC Press eBooks · doi:10.1201/b17644 · Cited by 16

Broad-spectrum downregulation of inflammatory cytokines by polydopamine nanoparticles to protect the injured spinal cord

Jiang, D., Ding, Y., Hu, S. P., Wei, G., Trujillo, C., Yang, Z., Wei, Z., Li, W., Liu, D., Li, C., et al. (2024) · Acta Biomaterialia · doi:10.1016/j.actbio.2024.12.028 · Cited by 15

Neuroaxonal Dystrophy in Australian Merino Lambs

Kessell, A., Finnie, J. W., Blumbergs, P. C., Manavis, J., & Jerrett, I. (2011) · Journal of Comparative Pathology · doi:10.1016/j.jcpa.2011.09.006 · Cited by 15

Fluid phase biomarkers in multiple sclerosis

Selmaj, K. W., Mycko, M. P., Furlan, R., & Rejdak, K. (2022) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001058 · Cited by 15

Plasma neurofilament light chain concentrations are elevated in youth‐onset type 2 diabetes and associated with neuropathy

Fridman, V., Sillau, S., Ritchie, A. M., Bockhorst, J., Coughlan, C. M., Araya, P., Espinosa, J. M., Smith, K. P., Lange, E. M., Lange, L. A., et al. (2023) · Journal of the Peripheral Nervous System · doi:10.1111/jns.12575 · Cited by 17

The genetic landscape of sporadic adult-onset degenerative ataxia: a multi-modal genetic study of 377 consecutive patients from the longitudinal multi-centre SPORTAX cohort

Beijer, D., Mengel, D., Önder, D., Wilke, C., Traschütz, A., Faber, J., Timmann, D., Boesch, S., Vielhaber, S., Klopstock, T., et al. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105715 · Cited by 16

Effects of Repeated Intrathecal Triamcinolone-Acetonide Application on Cerebrospinal Fluid Biomarkers of Axonal Damage and Glial Activity in Multiple Sclerosis Patients

Rommer, P. S., Kamin, F., Petzold, A., Tumani, H., Abu‐Mugheisib, M., Köehler, W., Hoffmann, F. A., Winkelmann, A., Benecke, R., & Zettl, U. K. (2014) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-014-0114-3 · Cited by 15

Phosphorylated neurofilament H (pNF-H) as a potential diagnostic marker for neurological disorders in horses

Razak, I. S. A., Divers, T. J., Morrow, J. K., Graves, A., Olsen, E., Johnson, A. L., & Mohammed, H. O. (2017) · Research in Veterinary Science · doi:10.1016/j.rvsc.2017.07.020 · Cited by 15

Neurofilament a biomarker of neurodegeneration in autoimmune encephalomyelitis

Gnanapavan, S., Grant, D., Pryce, G., Jackson, S., Baker, D., & Giovannoni, G. (2012) · Autoimmunity · doi:10.3109/08916934.2012.654865 · Cited by 13

Neurofilaments as biomarkers in neurological disorders

Khalil, M., Teunissen, C. E., Otto, M., Piehl, F., Sormani, M. P., Gattringer, T., Barro, C., Kappos, L., Comabella, M., Fazekas, F., et al. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0058-z · Cited by 1,988

Neurofilament Proteins as Body Fluid Biomarkers of Neurodegeneration in Multiple Sclerosis

Gresle, M., Butzkueven, H., & Shaw, G. (2011) · Multiple Sclerosis International · doi:10.1155/2011/315406 · Cited by 49

Neurofilament Protein as a Potential Biomarker of Axonal Degeneration in Experimental Autoimmune Encephalomyelitis

Wang, P., Jiang, L., Wang, C., Zhu, Z., & Lai, C. (2020) · Neurology India · doi:10.4103/0028-3886.280651 · Cited by 3

Anti-neurofilament antibodies and neurodegeneration: Markers and generators

Zmira, O., Halpern, A. I., & Drori, T. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2020.577248 · Cited by 13